Now that the shareprice has dipped below the offer price, who will be taking up their entitlement?Management seem to have really stuffed this up, I don't even know why they had to raise capital.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025